Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02595866 |
|---|---|
| Brief Title: | Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer |
| First Submitted : | November 3, 2015 |
| First Submitted that Met QC Criteria : | November 3, 2015 |
| First Posted : | November 4, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 24, 2022 |
| Last Update Posted : | December 28, 2022 |